Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Hemp/CBD and other cannabis startups share in equity deal count quarterly 2018-2019

In the second quarter of 2019, startups focusing on hemp and cannabidiol accounted for 25 percent of the number of equity deals including cannabis startups. The statistic illustrates the share of the global equity deal count including cannabis startups from 1st quarter 2014 to 2nd quarter 2019, by type/focus. Hemp-derived cannabidiol (CBD) is among the most promising compounds of cannabis. CBD has no psychoactive effects and could possibly be used in the treatment of anxiety, cognition, movement disorders, and pain.

Distribution of the global equity deal count including cannabis startups from Q1 2014 to Q2 2019, by type

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2019

Region

Worldwide

Survey time period

1st quarter 2014 to 2nd quarter 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical cannabis in the United Kingdom (UK)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.